Immune regulation in mitochondrial transfer: knowledge structure and emerging trends from a bibliometric perspective - Top-Institutions - MDSpire

Immune regulation in mitochondrial transfer: knowledge structure and emerging trends from a bibliometric perspective

  • By

  • Qiyu He

  • Zhimin Tan

  • Juan Xu

  • Tianhong Wang

  • Qian Li

  • Xiaoqiang Li

  • June 26, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Boston Children’s Hospital
    Boston Children’s Hospital

    Boston, Massachusetts

    Key Differentiators

    • Immunology
    • Pediatric Cardiology

  • #2

    Children’s Hospital of Philadelphia
    Children’s Hospital of Philadelphia

    Philadelphia, Pennsylvania

    Key Differentiators

    • Immunology
    • Mitochondrial Medicine

  • #3

    University of Texas MD Anderson Cancer Center
    University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology
    • Immunology

  • #4

    Institut national de la santé et de la recherche médicale
    Institut national de la santé et de la recherche médicale

    Paris, France

    Key Differentiators

    • Immunology
    • Public Health

  • #5

    University of London
    University of London

    London, United Kingdom

    Key Differentiators

    • Immunology
    • Cell Biology

Original Source(s)

Immune regulation in mitochondrial transfer: knowledge structure and emerging trends from a bibliometric perspective

  • by Qiyu He, Zhimin Tan, Juan Xu, Tianhong Wang, Qian Li, Xiaoqiang Li

  • June 26, 2026

Related Content

Joseph Fraumeni Jr., pioneering cancer genetics researcher, devoted his life to families like mine

Red cell distribution width: a novel and accessible predictor for immune checkpoint inhibitor-associated myocarditis—a retrospective cohort study

ESMO Breast Cancer 2026 Highlights: Pumitamig + DB-1305/BNT325

Harold Burstein, MD, PhD, and Ana C. Garrido-Castro, MD discuss results from the Pumitamig + DB-1305/BNT325 trial, which were presented at the 2026 ESMO Breast Cancer Congress.

  • June 26, 2026

  • 1 min